BIOZONE FORM 8-K 05/13/11

Company

Cocrystal Pharma, Inc.

Filed

May 19, 2011

Period of Report

May 16, 2011

Accession Number

0001469299-11-000343

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →